Looks like you’re on the US site. Choose another location to see content specific to your location
Hologic Expands Costa Rica Operations with Alajuela Site
Hologic has announced a new Costa Rica facility in Alajuela to house its Breast and Skeletal Health Solutions division, extending its already significant medtech operations in the country. Announced on 11 November 2026, construction is expected to run from March 2027 to December 2028, with the new site located approximately 2km from Hologic’s current Alajuela operations. The expansion reinforces Costa Rica’s growing role as a global medical device manufacturing hub and underpins Hologic’s ongoing commercial growth across women’s health.
The new building will accommodate the Breast and Skeletal Health Solutions division, including staff and assets. GYN Surgical Solutions will remain in dedicated space at the existing Alajuela site, as will Hologic’s Costa Rica shared services workers. CEO Joe Almeida positioned the additional capacity around supporting continued growth, with separate spaces enabling each global business unit to focus on its priorities. Specific investment figures, facility dimensions and job creation numbers were not disclosed at announcement; Hologic has indicated it will share further construction and relocation details once finalised. Acting Foreign Trade Minister Arianna Arce linked the investment to Costa Rica’s specialised medical technology sector and skilled workforce, while Procomer Executive Director Laura López flagged opportunities for local suppliers and talent.
The expansion sits within Hologic’s accelerating Costa Rica footprint, which now includes a specialist cybersecurity operations centre and a financial shared services centre alongside existing manufacturing. Costa Rica has emerged as one of the most strategically important medical device manufacturing locations globally, with a dense cluster of multinational operations around San José and Alajuela, strong technical workforce availability, favourable export economics via free trade zones, and established supply chain integration with US-based commercial operations. Hologic’s Breast and Skeletal Health Solutions franchise covers mammography systems, biopsy devices, breast health diagnostics and bone densitometry, with the division anchoring substantial commercial pull-through across US and international hospital procurement networks. The 2028 completion timeline aligns with Hologic’s longer-term growth planning horizon and provides capacity runway for anticipated US and international demand.
The commercial signal is a continued build-out of Costa Rica’s medical device manufacturing cluster, with Hologic’s Alajuela expansion reinforcing women’s health division growth capacity and strengthening nearshoring logistics for US and Latin American commercial supply. 2028 facility completion anchors near-term planning. Expect sustained investment in Costa Rica medtech manufacturing infrastructure and continued Hologic commercial momentum across women’s health through 2027 and 2028.
For the latest updates and in-depth insights into the world of Medical Devices, including breakthrough treatments, industry trends, and regulatory news, contact Albert Baines today!
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard